FZD7 and breast carcinoma: In this study, we establish FZD7 as a defining marker of tumor-initiating basal cells in MMTV-Wnt1-driven breast cancer, a well-characterized model of TNBC, a highly aggressive breast cancer subtype with poor prognosis and high risk of recurrence and metastasis.